Walgreens Boots Alliance, Inc. (NASDAQ:WBA) Shares Sold by Long Road Investment Counsel LLC

Long Road Investment Counsel LLC reduced its position in Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 7.6% during the 4th quarter, according to its most recent filing with the SEC. The firm owned 44,050 shares of the pharmacy operator’s stock after selling 3,600 shares during the quarter. Long Road Investment Counsel LLC’s holdings in Walgreens Boots Alliance were worth $411,000 as of its most recent filing with the SEC.

Several other institutional investors also recently bought and sold shares of the company. State Street Corp boosted its position in shares of Walgreens Boots Alliance by 18.0% during the 3rd quarter. State Street Corp now owns 42,997,580 shares of the pharmacy operator’s stock worth $385,258,000 after purchasing an additional 6,569,223 shares in the last quarter. Charles Schwab Investment Management Inc. raised its stake in Walgreens Boots Alliance by 19.9% in the 4th quarter. Charles Schwab Investment Management Inc. now owns 13,155,138 shares of the pharmacy operator’s stock valued at $122,737,000 after purchasing an additional 2,185,950 shares during the last quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC increased its stake in shares of Walgreens Boots Alliance by 12.1% during the 3rd quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 7,594,475 shares of the pharmacy operator’s stock valued at $68,046,000 after acquiring an additional 817,762 shares during the last quarter. Thompson Siegel & Walmsley LLC increased its stake in shares of Walgreens Boots Alliance by 15.5% during the 3rd quarter. Thompson Siegel & Walmsley LLC now owns 6,955,880 shares of the pharmacy operator’s stock valued at $62,325,000 after acquiring an additional 934,754 shares during the last quarter. Finally, Bank of New York Mellon Corp increased its stake in shares of Walgreens Boots Alliance by 9.6% during the 4th quarter. Bank of New York Mellon Corp now owns 5,432,383 shares of the pharmacy operator’s stock valued at $50,684,000 after acquiring an additional 478,061 shares during the last quarter. 58.59% of the stock is owned by institutional investors and hedge funds.

Walgreens Boots Alliance Trading Up 0.3 %

Shares of WBA stock opened at $11.26 on Tuesday. The stock has a 50-day simple moving average of $10.86 and a 200 day simple moving average of $9.77. Walgreens Boots Alliance, Inc. has a fifty-two week low of $8.08 and a fifty-two week high of $22.05. The stock has a market capitalization of $9.73 billion, a P/E ratio of -1.10, a P/E/G ratio of 1.31 and a beta of 0.62. The company has a quick ratio of 0.30, a current ratio of 0.64 and a debt-to-equity ratio of 0.68.

Walgreens Boots Alliance (NASDAQ:WBA) last announced its earnings results on Friday, January 10th. The pharmacy operator reported $0.51 earnings per share for the quarter, beating the consensus estimate of $0.38 by $0.13. Walgreens Boots Alliance had a positive return on equity of 17.61% and a negative net margin of 5.87%. The business had revenue of $39.50 billion during the quarter, compared to analysts’ expectations of $37.40 billion. During the same quarter last year, the business posted $0.66 earnings per share. The company’s quarterly revenue was up 7.6% on a year-over-year basis. On average, sell-side analysts expect that Walgreens Boots Alliance, Inc. will post 1.6 earnings per share for the current fiscal year.

Analysts Set New Price Targets

A number of analysts recently issued reports on WBA shares. Bank of America increased their target price on shares of Walgreens Boots Alliance from $7.50 to $8.50 and gave the stock an “underperform” rating in a research report on Monday, January 13th. Evercore ISI increased their target price on Walgreens Boots Alliance from $9.00 to $12.00 and gave the company an “in-line” rating in a research note on Monday, January 13th. StockNews.com began coverage on Walgreens Boots Alliance in a research note on Tuesday. They set a “hold” rating for the company. Wolfe Research upgraded Walgreens Boots Alliance to a “hold” rating in a research note on Monday, February 24th. Finally, Royal Bank of Canada increased their target price on Walgreens Boots Alliance from $9.00 to $12.00 and gave the stock a “sector perform” rating in a research report on Wednesday, January 15th. Four equities research analysts have rated the stock with a sell rating, nine have assigned a hold rating and two have assigned a buy rating to the stock. According to data from MarketBeat.com, Walgreens Boots Alliance presently has a consensus rating of “Hold” and an average target price of $11.54.

About Walgreens Boots Alliance

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.